|
Volumn 32, Issue , 2008, Pages S5-S10
|
The metabolic syndrome and cardiovascular risk: Implications for clinical practice
|
Author keywords
Cardiovascular disease; Metabolic syndrome; Risk factors
|
Indexed keywords
APOLIPOPROTEIN B;
C REACTIVE PROTEIN;
FIBRINOGEN;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN;
HOMOCYSTEINE;
TRIACYLGLYCEROL;
ARTERY COMPLIANCE;
BLOOD PRESSURE;
BODY MASS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL EVALUATION;
CLINICAL PRACTICE;
CONFERENCE PAPER;
CORONARY ARTERY DISEASE;
DIABETIC NEUROPATHY;
DIABETIC RETINOPATHY;
FAMILY HISTORY;
FEMALE;
FIBRINOGEN BLOOD LEVEL;
GLUCOSE BLOOD LEVEL;
HEART INFARCTION;
HEART OUTPUT;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
KIDNEY FUNCTION;
LONG TERM CARE;
MALE;
METABOLIC SYNDROME X;
OBESITY;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
PROGNOSIS;
RISK FACTOR;
SMOKING;
STROKE;
TRIACYLGLYCEROL BLOOD LEVEL;
VASCULAR RESISTANCE;
WORLD HEALTH ORGANIZATION;
ADULT;
AGED;
CARDIOVASCULAR DISEASES;
HEALTH SURVEYS;
HUMANS;
METABOLIC SYNDROME X;
MIDDLE AGED;
PROGNOSIS;
RISK ASSESSMENT;
UNITED STATES;
|
EID: 43449087948
PISSN: 03070565
EISSN: 14765497
Source Type: Journal
DOI: 10.1038/ijo.2008.28 Document Type: Article |
Times cited : (40)
|
References (10)
|